21 CFR 522.158

§ 522.158 Bedinvetmab.

United States · 21 CFR — Food and Drugs · Status: effective

Cite this

Citation: 21 CFR 522.158, § 522.158 Bedinvetmab, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/87391
Permanent ID: ys:prov:87391@1
SHA-256: e0d59840351c3e993b25744d5e375dee18d0fa256767d3e9f39626c3fed09ccc

The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.

Full text

(a) Specifications. Each single-use vial contains 5, 10, 15, 20, or 30 milligrams (mg) bedinvetmab in an extractable volume of 1 milliliter. (b) Sponsor. See No. 054771 in § 510.600(c) of this chapter. (c) Conditions of use—(1) Amount. Administer 0.23 mg/pound (0.5 mg/kilogram) body weight monthly by subcutaneous injection. (2) Indications for use. For the control of pain associated with osteoarthritis in dogs. (3) Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Legislative history

This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.